Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Safe Medical Devices for Children (2005) (ISBN 0309096316) Marilyn J. Field and Hugh Tilson, Editors, Committee on Postmarket Surveillance of Pediatric Medical Devices


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (2011) (ISBN 0309212421) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (2010) (ISBN 0309158494) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Enhancing Food Safety:The Role of the Food and Drug Administration (2010) (ISBN 0309152739) Robert B. Wallace and Maria Oria, Editors; Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food; National Research Council


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• Innovation and Invention in Medical Devices: Workshop Summary (2001) (ISBN 0309082552) Kathi E. Hanna, Frederick J. Manning, Peter Bouxsein, and Andrew Pope, Editors, Based on a Workshop of the Roundtable on Research and Development of Drugs, Biologics, and Medical Devices, Board on Health Sciences Policy


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary (2012) (ISBN 0309253942) Steve Olson and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (2007) (ISBN 0309109868) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• The Changing Economics of Medical Technology (1991) (ISBN 030904491X) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Food and Drug Administration Advisory Committees (1992) (ISBN 0309048370) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (2011) (ISBN 0309212804) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council